Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failureNina Worel, Hildegard Greinix, Felix Keil et al.|Journal of Clinical Apheresis|2016Cited by 36
HLA-C KIR-Ligands Determine the Impact of Anti-Thymocyte Globulin (ATG) on Graft versus Host and Graft versus Leukemia Effects Following Hematopoietic Stem Cell TransplantationJohannes Clausen, David Nachbaur, Alexandra Böhm et al.|Biomedicines|2017Cited by 12
BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trialFelix Keil, Thomas Pabst, Antonia Müller et al.|EClinicalMedicine|2023Cited by 6
Comparison of Benefits and Risks Associated with Anti-T-Lymphocyte Globulin (ATLG) Serotherapy in Methotrexate (MTX)- versus Mycophenolate Mofetil (MMF)-Based Hematopoietic Stem Cell TransplantationAlexander Nikoloudis, Johannes Clausen, Irene Straßl et al.|Transplantology|2023Cited by 3
BendaEAM Versus BEAM as Conditioning Regimen for ASCT in Patients with Relapsed Lymphoma (BEB): A Multicentre, Randomised, Phase II TrialFelix Keil, Thomas Pabst, Antonia Müller et al.|SSRN Electronic Journal|2023Cited by 0